Ensign Peak Advisors, Inc Sera Prognostics, Inc. Transaction History

Ensign Peak Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.6 - $11.69 $99,926 - $208,596	-17,844 Reduced 14.87%	102,156 $604,000
Q1 2024 May 14, 2024	SELL	$5.05 - $10.0 $686,699 - $1.36 Million	-135,980 Reduced 53.12%	120,000 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$1.65 - $6.85 $392,488 - $1.63 Million	237,872 Added 1313.63%	255,980 $1.53 Million
Q1 2022 May 16, 2022	BUY	$2.96 - $8.8 $53,599 - $159,350	18,108 New	18,108 $69,000

20.3M

120K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $201M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.